Treace Corp (TMCI) Enterprise Value to EBITDA Ratio
Treace Medical Concepts (TMCI) is expanding its line of foot correction implants and entering new regions, which minimizes market risks. The business relies on patents and surgeon trust, while the EV/EBITDA ratio, as captured on this daily price chart, stands at 0.00. Margin stability is maintained through the control of insurance reimbursements. Simultaneously, Treace Medical Concepts (TMCI) is implementing eco-friendly packaging standards and reducing energy costs in the production of high-precision systems.
Comprehensive metric breakdowns and analytics for treace.com (TMCI)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Treace Medical Concepts|TMCI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Treace Medical Concepts, Inc.|TMCI - Company Total Debt|Debts to Book Capitalization Treace Corp|TMCI - Long-Term Debt|Company Short-Term Debts Treace Medical Concepts|Quick Ratio treace.com
- financial results and valuation multiples details:
TMCI - Net Financial Result|Projected Future Earnings Treace Medical Concepts|TMCI - Price to Earnings Ratio|Forward P/E Multiple Treace Medical Concepts|TMCI - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Treace Corp|TMCI - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Treace Medical Concepts|TMCI - Earnings per share for the trailing year|Quarterly EPS earnings growth treace.com|TMCI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Treace Medical Concepts
Analysis of all company metrics:Treace Medical TMCI
Investors use this tool to determine an asset's fair value while accounting for debt load. The metric compares Enterprise Value (EV) to Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) to identify price overheating. For Treace Medical Concepts (TMCI), this calculation confirms the capitalization of the Lapiplasty system's technological leadership in foot surgery. Analyzing the company's current EV/EBITDA multiple allows for the precise synchronization of the capital planning horizon.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD (ReWalk Robotics Ltd.) - Enterprise Value to EBITDA Ratio|AMIX: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|BBLG: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AXNX|BIOL - Company Value to EBITDA|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO Bio - EV/EBITDA Multiple
